Financial News
Latest News about MRNA
Recent news which mentions MRNA
Why Novavax Has Limited Downside from Here
February 21, 2022
From InvestorPlace
From InvestorPlace
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
February 21, 2022
From InvestorPlace
7 Momentum Stocks to Buy While the Market Corrects
February 21, 2022
Tags
F
Market News
NASDAQ:MRNA,NYSE:DVN,NYSE:F,NYSE:BBWI,NASDAQ:NVDA,NYSE:IT,NYSE:SPG,NYSE:EXR,NASDAQ:TSLA,NYSE:VSCO,
From InvestorPlace
From Motley Fool
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Barron's Latest Picks And Pans: DoorDash, General Motors, Moderna, General Electric And More
February 19, 2022
From Benzinga
1 Crucial Thing to Look For in Moderna's Earnings Report
February 19, 2022
From Motley Fool
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
February 18, 2022
From Benzinga
Ocugen Stock Is a Fairy Tale in Need of a Happy Ending
February 18, 2022
From InvestorPlace
2 Popular Robinhood Stocks to Sell Right Now
February 18, 2022
From Motley Fool
7 Stocks With Earnings Reports Next Week
February 17, 2022
From InvestorPlace
Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters
February 17, 2022
Tickers
MRNA
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
From Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
From Benzinga
2 Reasons Why Pfizer Might Crush Moderna in the mRNA Market. And 1 Reason Why Moderna May Stay Ahead.
February 17, 2022
From Motley Fool
3 Top Biotech Stocks to Buy for the Long Haul
February 17, 2022
From Motley Fool
3 Moonshot Stocks For 2022
February 16, 2022
From InvestorPlace
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
From InvestorPlace
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
From Benzinga
U.S. excess death toll has climbed above one million during the pandemic; ‘We’ve never seen anything like it,’ says CDC official
February 16, 2022
From MarketWatch
Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs
February 16, 2022
Tickers
MRNA
From Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
From Benzinga
Novavax Investors Can Finally Breathe a Sigh of Relief
February 16, 2022
From Motley Fool
Will Novavax Stock Ever Hit $300 Again?
February 16, 2022
From Motley Fool
The end of the pandemic may be in sight, says Moderna CEO
February 16, 2022
From MarketWatch
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
From InvestorPlace
Twilio’s Post-Pandemic Story Looks Good
February 15, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
